David E Victorson1, Seung Choi, Marc A Judson, David Cella. 1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 2205 Tech Drive, Suite 2-120, Chicago, IL, USA, d-victorson@northwestern.edu.
Abstract
PURPOSE: Sarcoidosis is a multisystem disease that can negatively impact health-related quality of life (HRQL) across generic (e.g., physical, social and emotional wellbeing) and disease-specific (e.g., pulmonary, ocular, dermatologic) domains. Measurement of HRQL in sarcoidosis has largely relied on generic patient-reported outcome tools, with little disease-specific measures available. The purpose of this paper is to present the development and testing of disease-specific item banks and short forms of lung, skin and eye problems, which are a part of a new patient-reported outcome (PRO) instrument called the sarcoidosis assessment tool. METHODS: After prioritizing and selecting the most important disease-specific domains, we wrote new items to reflect disease-specific problems by drawing from patient focus group and clinician expert survey data that were used to create our conceptual model of HRQL in sarcoidosis. Item pools underwent cognitive interviews by sarcoidosis patients (n = 13), and minor modifications were made. These items were administered in a multi-site study (n = 300) to obtain item calibrations and create calibrated short forms using item response theory (IRT) approaches. RESULTS: From the available item pools, we created four new item banks and short forms: (1) skin problems, (2) skin stigma, (3) lung problems, and (4) eye Problems. We also created and tested supplemental forms of the most common constitutional symptoms and negative effects of corticosteroids. CONCLUSIONS: Several new sarcoidosis-specific PROs were developed and tested using IRT approaches. These new measures can advance more precise and targeted HRQL assessment in sarcoidosis clinical trials and clinical practice.
PURPOSE:Sarcoidosis is a multisystem disease that can negatively impact health-related quality of life (HRQL) across generic (e.g., physical, social and emotional wellbeing) and disease-specific (e.g., pulmonary, ocular, dermatologic) domains. Measurement of HRQL in sarcoidosis has largely relied on generic patient-reported outcome tools, with little disease-specific measures available. The purpose of this paper is to present the development and testing of disease-specific item banks and short forms of lung, skin and eye problems, which are a part of a new patient-reported outcome (PRO) instrument called the sarcoidosis assessment tool. METHODS: After prioritizing and selecting the most important disease-specific domains, we wrote new items to reflect disease-specific problems by drawing from patient focus group and clinician expert survey data that were used to create our conceptual model of HRQL in sarcoidosis. Item pools underwent cognitive interviews by sarcoidosispatients (n = 13), and minor modifications were made. These items were administered in a multi-site study (n = 300) to obtain item calibrations and create calibrated short forms using item response theory (IRT) approaches. RESULTS: From the available item pools, we created four new item banks and short forms: (1) skin problems, (2) skin stigma, (3) lung problems, and (4) eye Problems. We also created and tested supplemental forms of the most common constitutional symptoms and negative effects of corticosteroids. CONCLUSIONS: Several new sarcoidosis-specific PROs were developed and tested using IRT approaches. These new measures can advance more precise and targeted HRQL assessment in sarcoidosis clinical trials and clinical practice.
Authors: David S Tulsky; Pamela A Kisala; David Victorson; Denise Tate; Allen W Heinemann; Dagmar Amtmann; David Cella Journal: Arch Phys Med Rehabil Date: 2011-10 Impact factor: 3.966
Authors: Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen Journal: Ophthalmic Epidemiol Date: 2010-08 Impact factor: 1.648
Authors: Daniel J Buysse; Lan Yu; Douglas E Moul; Anne Germain; Angela Stover; Nathan E Dodds; Kelly L Johnston; Melissa A Shablesky-Cade; Paul A Pilkonis Journal: Sleep Date: 2010-06 Impact factor: 5.849
Authors: Amit Suresh Patel; Richard J Siegert; Daniel Creamer; Genevieve Larkin; Toby M Maher; Elisabetta A Renzoni; Athol U Wells; Irene J Higginson; Surinder S Birring Journal: Thorax Date: 2012-10-12 Impact factor: 9.139
Authors: John M Salsman; Crystal L Park; Elizabeth A Hahn; Mallory A Snyder; Login S George; Michael F Steger; Thomas Merluzzi; David Cella Journal: Qual Life Res Date: 2018-06-20 Impact factor: 4.147
Authors: Brooke M Currie; Evan W Davies; Amélie Beaudet; Larissa Stassek; Leah Kleinman; Robert P Baughman Journal: BMC Pulm Med Date: 2021-11-12 Impact factor: 3.317
Authors: Cristina Drenkard; Kristina A Theis; Timothy T Daugherty; Charles G Helmick; Charmayne Dunlop-Thomas; Gaobin Bao; Laura Aspey; Tené T Lewis; S Sam Lim Journal: Lupus Sci Med Date: 2022-08